🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
The primary objective of this study is to determine the percentage of patie...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2009-03
Trial ID
NCT00951457
Treatments Being Tested
Background: Adult T-cell leukemia (ATL) is a rare blood cancer. Researcher...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2017-01-19
Trial ID
NCT02689453
Treatments Being Tested
Aims and objectives * Assessment of the efficacy of the study treatment in...
Status
Completed
Location
Hanuschkrankenhaus Wien
Start Date
2008-02
Trial ID
NCT01392079
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
Medizinische Universitaetsklinik I at the University of Cologne
Start Date
2003-11
Trial ID
NCT00634881
Treatments Being Tested
This study aims to assess the short term efficacy of a combination immunoch...
Status
Completed
Location
University of Cologne
Start Date
2005-01
Trial ID
NCT00147901
Treatments Being Tested
Peripheral T cell lymphomas comprise 10-15% of all malignant lymphomas. The...
Status
Unknown
Location
University of Göttingen
Start Date
2008-02
Trial ID
NCT00725231
Treatments Being Tested